Patents by Inventor Bastian Zimmer
Bastian Zimmer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240327796Abstract: The presently disclosed subject matter provides for in vitro methods of inducing differentiation of human stem cells into neural crest, cranial placode or non-neuro ectoderm precursors, and cells generated by such methods. The presently disclosed subject matter also provides for uses of such cells for treating neurodegenerative and pituitary disorders.Type: ApplicationFiled: March 15, 2024Publication date: October 3, 2024Applicant: MEMORIAL SLOAN-KETTERING CANCER CENTERInventors: Lorenz STUDER, Bastian ZIMMER, Jason TCHIEU
-
Patent number: 11959104Abstract: The presently disclosed subject matter provides for in vitro methods of inducing differentiation of human stem cells into neural crest, cranial placode or non-neuro ectoderm precursors, and cells generated by such methods. The presently disclosed subject matter also provides for uses of such cells for treating neurodegenerative and pituitary disorders.Type: GrantFiled: April 4, 2022Date of Patent: April 16, 2024Assignee: MEMORIAL SLOAN-KETTERING CANCER CENTERInventors: Lorenz Studer, Bastian Zimmer, Jason Tchieu
-
Publication number: 20240067924Abstract: Cranial placodes are embryonic structures essential for sensory and endocrine organ development. The efficient derivation of cranial placodes from human pluripotent stem cells is disclosed where the timed removal of the BMP inhibitor Noggin, a component of the dual-SMAD inhibition strategy of neural induction, triggers placode induction at the expense of CNS fates. Further fate specification at the pre-placode stage enables the selective generation of placode-derived trigeminal ganglia capable of in vivo engraftment, mature lens fibers and anterior pituitary hormone-producing cells that upon transplantation produce hormones including, but not limited to, human growth hormone and adrenocortiocotropic hormone in vivo. Alternatively, anterior pituitary hormone-producing cells are generated in cell culture systems in vitro.Type: ApplicationFiled: December 21, 2022Publication date: February 29, 2024Applicant: MEMORIAL SLOAN-KETTERING CANCER CENTERInventors: Stuart Chambers, Lorenz Studer, Zehra Dincer, Bastian Zimmer
-
Patent number: 11591567Abstract: Cranial placodes are embryonic structures essential for sensory and endocrine organ development. The efficient derivation of cranial placodes from human pluripotent stem cells is disclosed where the timed removal of the BMP inhibitor Noggin, a component of the dual-SMAD inhibition strategy of neural induction, triggers placode induction at the expense of CNS fates. Further fate specification at the pre-placode stage enables the selective generation of placode-derived trigeminal ganglia capable of in vivo engraftment, mature lens fibers and anterior pituitary hormone-producing cells that upon transplantation produce hormones including, but not limited to, human growth hormone and adrenocortiocotropic hormone in vivo. Alternatively, anterior pituitary hormone-producing cells are generated in cell culture systems in vitro.Type: GrantFiled: April 2, 2019Date of Patent: February 28, 2023Assignee: MEMORIAL SLOAN-KETTERING CANCER CENTERInventors: Stuart Chambers, Lorenz Studer, Zehra Dincer, Bastian Zimmer
-
Publication number: 20220228123Abstract: The presently disclosed subject matter provides for in vitro methods of inducing differentiation of human stem cells into neural crest, cranial placode or non-neuro ectoderm precursors, and cells generated by such methods. The presently disclosed subject matter also provides for uses of such cells for treating neurodegenerative and pituitary disorders.Type: ApplicationFiled: April 4, 2022Publication date: July 21, 2022Applicant: MEMORIAL SLOAN-KETTERING CANCER CENTERInventors: Lorenz STUDER, Bastian ZIMMER, Jason TCHIEU
-
Patent number: 11326148Abstract: The presently disclosed subject matter provides for in vitro methods of inducing differentiation of human stem cells into neural crest, cranial placode or non-neuro ectoderm precursors, and cells generated by such methods. The presently disclosed subject matter also provides for uses of such cells for treating neurodegenerative and pituitary disorders.Type: GrantFiled: August 3, 2018Date of Patent: May 10, 2022Assignee: MEMORIAL SLOAN-KETTERING CANCER CENTERInventors: Lorenz Studer, Bastian Zimmer, Jason Tchieu
-
Patent number: 10747413Abstract: Embodiments relate to apparatuses, methods and computer programs for controlling a machine. The apparatus is suitable for a mobile communication device for providing a sensor input signal to a machine control entity to control a machine. The apparatus comprises one or more sensor modules for providing first user input sensor data and second user input sensor data. The apparatus further comprises a control module configured to determine the sensor input signal based on the first user input sensor data and the second user input sensor data. The control module is further configured to provide the sensor input signal for sensor data processing to the machine control entity to control the machine via an interface.Type: GrantFiled: November 2, 2016Date of Patent: August 18, 2020Assignee: Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.Inventors: Daniel Schneider, Thomas Kuhn, Rasmus Adler, Viet Yen Nguyen, Patrik Feth, Emilia Cioroaica, Bastian Zimmer, Martin Kremmer, Thomas Floerchinger, Benjamin Neermann, Norbert Fritz, Stefan Volz
-
Publication number: 20200199530Abstract: The presently disclosed subject matter provides in vitro methods of inducing differentiation of stem cells to neural crest, cranial placode or non-neuro ectoderm precursors, and cells generated by such methods. The presently disclosed subject matter also provides uses of such cells for treating neurodegenerative and pituitary disorders.Type: ApplicationFiled: March 5, 2020Publication date: June 25, 2020Applicant: MEMORIAL SLOAN-KETTERING CANCER CENTERInventors: Lorenz Studer, Bastian Zimmer, Jason Tchieu
-
Publication number: 20190225939Abstract: Cranial placodes are embryonic structures essential for sensory and endocrine organ development. The efficient derivation of cranial placodes from human pluripotent stem cells is disclosed where the timed removal of the BMP inhibitor Noggin, a component of the dual-SMAD inhibition strategy of neural induction, triggers placode induction at the expense of CNS fates. Further fate specification at the pre-placode stage enables the selective generation of placode-derived trigeminal ganglia capable of in vivo engraftment, mature lens fibers and anterior pituitary hormone-producing cells that upon transplantation produce hormones including, but not limited to, human growth hormone and adrenocortiocotropic hormone in vivo. Alternatively, anterior pituitary hormone-producing cells are generated in cell culture systems in vitro.Type: ApplicationFiled: April 2, 2019Publication date: July 25, 2019Applicant: MEMORIAL SLOAN-KETTERING CANCER CENTERInventors: Stuart Chambers, Lorenz Studer, Zehra Dincer, Bastian Zimmer
-
Patent number: 10273452Abstract: Cranial placodes are embryonic structures essential for sensory and endocrine organ development. The efficient derivation of cranial placodes from human pluripotent stem cells is disclosed where the timed removal of the BMP inhibitor Noggin, a component of the dual-SMAD inhibition strategy of neural induction, triggers placode induction at the expense of CNS fates. Further fate specification at the pre-placode stage enables the selective generation of placode-derived trigeminal ganglia capable of in vivo engraftment, mature lens fibers and anterior pituitary hormone-producing cells that upon transplantation produce hormones including, but not limited to, human growth hormone and adrenocortiocotropic hormone in vivo. Alternatively, anterior pituitary hormone-producing cells are generated in cell culture systems in vitro.Type: GrantFiled: May 19, 2016Date of Patent: April 30, 2019Assignee: MEMORIAL SLOAN-KETTERING CANCER CENTERInventors: Stuart Chambers, Lorenz Studer, Zehra Dincer, Bastian Zimmer
-
Publication number: 20190071643Abstract: The presently disclosed subject matter provides for in vitro methods of inducing differentiation of human stem cells into neural crest, cranial placode or non-neuro ectoderm precursors, and cells generated by such methods. The presently disclosed subject matter also provides for uses of such cells for treating neurodegenerative and pituitary disorders.Type: ApplicationFiled: August 3, 2018Publication date: March 7, 2019Applicant: MEMORIAL SLOAN-KETTERING CANCER CENTERInventors: Lorenz STUDER, Bastian ZIMMER, Jason TCHIEU
-
Publication number: 20170228145Abstract: Embodiments relate to apparatuses, methods and computer programs for controlling a machine. The apparatus is suitable for a mobile communication device for providing a sensor input signal to a machine control entity to control a machine. The apparatus comprises one or more sensor modules for providing first user input sensor data and second user input sensor data. The apparatus further comprises a control module configured to determine the sensor input signal based on the first user input sensor data and the second user input sensor data. The control module is further configured to provide the sensor input signal for sensor data processing to the machine control entity to control the machine via an interface.Type: ApplicationFiled: November 2, 2016Publication date: August 10, 2017Inventors: Daniel Schneider, Thomas Kuhn, Rasmus Adler, Viet Yen Nguyen, Patrik Feth, Emilia Cioroaica, Bastian Zimmer, Martin Kremmer, Thomas Floerchinger, Benjamin Neermann, Norbert Fritz, Stefan Volz
-
Publication number: 20160326491Abstract: Cranial placodes are embryonic structures essential for sensory and endocrine organ development. The efficient derivation of cranial placodes from human pluripotent stem cells is disclosed where the timed removal of the BMP inhibitor Noggin, a component of the dual-SMAD inhibition strategy of neural induction, triggers placode induction at the expense of CNS fates. Further fate specification at the pre-placode stage enables the selective generation of placode-derived trigeminal ganglia capable of in vivo engraftment, mature lens fibers and anterior pituitary hormone-producing cells that upon transplantation produce hormones including, but not limited to, human growth hormone and adrenocortiocotropic hormone in vivo. Alternatively, anterior pituitary hormone-producing cells are generated in cell culture systems in vitro.Type: ApplicationFiled: May 19, 2016Publication date: November 10, 2016Inventors: Stuart Chambers, Lorenz Studer, Zehra Dincer, Bastian Zimmer